Our friendly staff is here to help you book your appointment
While it may serve as a complementary option for some individuals with metabolic disorders, it should not replace clinically approved therapies
Not every patient will benefit, and those who do will benefit in different ways depending on their diagnoses, BMI, and which program they qualify for
L.GosnellM
1 GLP-1 RAs should be titrated until A1C goal, maximum dose, or patient tolerability has been met
Retrospective EHR-based studies can capture real-world associations, yet they are especially vulnerable to residual confounding, treatment-selection bias, differences in healthcare engagement, and unmeasured disease biology